Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Free Cash Flow (2022 - 2023)

Bluejay Diagnostics' Free Cash Flow history spans 2 years, with the latest figure at -$2.9 million for Q4 2023.

  • For Q4 2023, Free Cash Flow fell 41.55% year-over-year to -$2.9 million; the TTM value through Dec 2023 reached -$9.0 million, down 15.87%, while the annual FY2024 figure was -$8.1 million, 9.89% up from the prior year.
  • Free Cash Flow for Q4 2023 was -$2.9 million at Bluejay Diagnostics, down from -$1.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.2 million in Q3 2023 and bottomed at -$3.3 million in Q1 2023.